quarterly sales
Merck & Co.’s Keytruda Achieves $7 Billion in Quarterly Sales, Surpassing Expectations
Merck & Co., Keytruda, quarterly sales, Winrevair, pharmaceuticals, oncology
Sanofi’s Dupixent Sales Surpass €3 Billion for the First Time
Sanofi, Dupixent, quarterly sales, record high, asthma medicine, earnings forecast